Skip to main content

Advertisement

Log in

Berberine Attenuates Inflammation Associated with Delayed-Type Hypersensitivity via Suppressing Th1 Response and Inhibiting Apoptosis

  • ORIGINAL ARTICLE
  • Published:
Inflammation Aims and scope Submit manuscript

ABSTRACT

Berberine, one of the active alkaloids from Rhizoma Coptidis, has been indicated to have anti-inflammatory and immunosuppressive properties. The aim of this study was to determine the role of berberine on ovalbumin (OVA)-induced delayed-type hypersensitivity (DTH) and its potential mechanisms. Berberine treatment significantly reduced footpad swelling, inflammatory cells infiltration, anti-OVA IgG levels, IgE concentration in serum, and the tetramer+CD8+ cells. In homogenized footpad tissue, the production of Th1-mediated cytokines including IFN-γ, TNF-α, and IL-2 were suppressed following the administration of berberine. Detailed studies revealed that berberine prevented differentiation into Th1 cells in the OVA-primed lymphocytes, resulting from suppressing the expression of T-bet and secretion of IFN-γ but not IL-4. Concanavalin A stimulation assay and MTT assay also indicated inhibiting effect of berberine treatment on IFN-γ production and decreased cytotoxicity in lymphocytes proliferation, respectively. Additionally, berberine obviously decreased the cell apoptosis and enzymatic activity of caspase-3, which was further confirmed by the facts that berberine clearly lowered Bax/Bcl-2 ratio and expression of cleaved caspase-3 protein. On correlation analysis, the percentage of apoptotic cells showed a significant positive relationship with IFN-γ/IL-4 ratio of supernatant from footpad tissue in berberine-treated DTH mice. These results demonstrated that berberine attenuated Th1-mediated inflammation in OVA-induced DTH by curbing Th1 response and inhibiting cell apoptosis, suggesting a therapeutic potential for berberine for the treatment of type IV hypersensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Wang, S., Y. Fan, R.C. Brunham, and X. Yang. 1999. IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. European Journal of Immunology 29: 3782–3792.

    Article  CAS  PubMed  Google Scholar 

  2. Salem, M.L., G. Matsuzaki, K. Kishihara, G.A. Madkour, and K. Nomoto. 2000. β-estradiol suppresses t cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. International Archives of Allergy and Immunology 121: 161–169.

    Article  CAS  PubMed  Google Scholar 

  3. Lu, T.X., J. Hartner, E.J. Lim, V. Fabry, M.K. Mingler, E.T. Cole, et al. 2011. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. Journal of Immunology 187: 3362–3373.

    Article  CAS  Google Scholar 

  4. Khan, D.A. 2016. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Annals of Allergy, Asthma, and Immunology 117: 115–120.

    Article  CAS  PubMed  Google Scholar 

  5. Pavlos, R., S. Mallal, D. Ostrov, S. Buus, I. Metushi, B. Peters, et al. 2015. T cell-mediated hypersensitivity reactions to drugs. Annual Review of Medicine 66: 439–454.

    Article  CAS  PubMed  Google Scholar 

  6. Kumar, A., Chopra K. Ekavali, M. Mukherjee, R. Pottabathini, and D.K. Dhull. 2015. Current knowledge and pharmacological profile of berberine: an update. European Journal of Pharmacology 761: 288–297.

    Article  CAS  PubMed  Google Scholar 

  7. Pang, B., Zhao L.H., Zhou, Q., Zhao, T.Y., Wang, H., and Gu, C.J., et al. 2015. Application of berberine on treating type 2 diabetes mellitus. International Journal of Endocrinology: 905749.

  8. Tillhon, M., L.M. Guamán Ortiz, P. Lombardi, and A.I. Scovassi. 2012. Berberine: new perspectives for old remedies. Biochemical Pharmacology 84: 1260–1267.

    Article  CAS  PubMed  Google Scholar 

  9. Wang, Z., Z. Chen, S. Yang, Y. Wang, Z. Huang, J. Gao, et al. 2014. Berberine ameliorates collagen-induced arthritis in rats associated with anti-inflammatory and anti-angiogenic effects. Inflammation 37: 1789–1798.

    Article  CAS  PubMed  Google Scholar 

  10. Mahmoudi, M., S. Zamani Taghizadeh Rabe, M. Balali-Mood, G. Karimi, B. Memar, M. Rahnama, et al. 2016. Immunotoxicity induced in mice by subacute exposure to berberine. Journal of Immunotoxicology 13: 255–262.

    Article  CAS  PubMed  Google Scholar 

  11. Yang, N., J. Wang, C. Liu, Y. Song, S. Zhang, J. Zi, et al. 2014. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients. Annals of Allergy, Asthma, and Immunology 113: 556–564.

    Article  CAS  PubMed  Google Scholar 

  12. Li, Z., J. Zheng, N. Zhang, and C. Li. 2016. Berberine improves airway inflammation and inhibits NF-κB signaling pathway in an ovalbumin-induced rat model of asthma. Journal of Asthma 13: 1–7.

    Article  Google Scholar 

  13. Kim, B.Y., H.R. Park, H.G. Jeong, and S.W. Kim. 2015. Berberine reduce allergic inflammation in a house dust mite allergic rhinitis mouse model. Rhinology 53: 353–358.

    CAS  PubMed  Google Scholar 

  14. Zhou, L., M.M. Chong, and D.R. Littman. 2009. Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646–655.

    Article  CAS  PubMed  Google Scholar 

  15. Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Annals of Allergy, Asthma, and Immunology 85: 9–18.

    Article  CAS  PubMed  Google Scholar 

  16. Yan, F., L. Wang, Y. Shi, H. Cao, L. Liu, M.K. Washington, et al. 2012. Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 302: G504–514.

    Article  CAS  PubMed  Google Scholar 

  17. Yang, Y., J. Qi, Q. Wang, L. Du, Y. Zhou, H. Yu, et al. 2013. Berberine suppresses Th17 and dendritic cell responses. Investigative Ophthalmology & Visual Science 54: 2516–2522.

    Article  CAS  Google Scholar 

  18. Caliceti, C., P. Franco, S. Spinozzi, A. Roda, and A.F. Cicero. 2016. Berberine: new insights from pharmacological aspects to clinical evidences in the management of metabolic disorders. Current Medicinal Chemistry 23: 1460–1476.

    Article  CAS  PubMed  Google Scholar 

  19. Kroemer, G., and S.J. Martin. 2005. Caspase-independent cell death. Nature Medicine 11: 725–730.

    Article  PubMed  Google Scholar 

  20. Chen, Z.Z. 2016. Berberine induced apoptosis of human osteosarcoma cells by inhibiting phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signal pathway activation. Iranian Journal of Public Health 45: 578–585.

    PubMed  PubMed Central  Google Scholar 

  21. Zhang, Q., H. Bian, L. Guo, and H. Zhu. 2016. Pharmacologic preconditioning with berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron. American Journal of Translational Research 8: 1197–1207.

    PubMed  PubMed Central  Google Scholar 

  22. Guo, J., Wang, L., Wang, L., Qian, S., Zhang, D., and Fang, .J, et al. 2016. Berberine protects human umbilical vein endothelial cells against lps-induced apoptosis by blocking JNK-mediated signaling. Evidence-based Complementary and Alternative Medicine: 6983956.

  23. Adil, M., A.D. Kandhare, G. Dalvi, P. Ghosh, S. Venkata, K.S. Raygude, et al. 2016. Ameliorative effect of berberine against gentamicin-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Renal Failure 38: 996–1006.

    Article  CAS  PubMed  Google Scholar 

  24. Lu, K.L., L.N. Wang, D.D. Zhang, W.B. Liu, and W.N. Xu. 2016. Berberine attenuates oxidative stress and hepatocytes apoptosis via protecting mitochondria in blunt snout bream Megalobrama amblycephala fed high-fat diets. Fish Physiology and Biochemistry. doi:10.1007/s10695-016-0268-5.

    PubMed  Google Scholar 

  25. Wang, B., H. Fujisawa, L. Zhuang, I. Freed, B.G. Howell, S. Shahid, G.M. Shivji, et al. 2000. CD4+ Th1 and CD8+ type 1 cytotoxic t cells both play a crucial role in the full development of contact hypersensitivity. Journal of Immunology 165: 6783–6790.

    Article  CAS  Google Scholar 

  26. Barrera, L., F. Mendoza, J. Zuñiga, A. Estrada, A.C. Zamora, E.I. Melendro, et al. 2008. Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. American Journal of Respiratory and Critical Care Medicine 177: 44–55.

    Article  CAS  PubMed  Google Scholar 

  27. Kwon, H.K., G.C. Kim, J.S. Hwang, Y. Kim, C.S. Chae, J.H. Nam, et al. 2016. Transcription factor NFAT1 controls allergic contact hypersensitivity through regulation of activation induced cell death program. Science Reports 6: 19453.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGEMENTS

This study was supported by the grants from the Health and Family Planning Commission of Hubei Province (No. 2013Z-Z01) and the Natural Science Foundation of Hubei Province of China (No. 2015CFA096).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zebin Chen.

Ethics declarations

Conflicts of Interest

The authors declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Z., Chen, Z., Chen, T. et al. Berberine Attenuates Inflammation Associated with Delayed-Type Hypersensitivity via Suppressing Th1 Response and Inhibiting Apoptosis. Inflammation 40, 221–231 (2017). https://doi.org/10.1007/s10753-016-0472-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-016-0472-6

KEY WORDS

Navigation